Physician

Timothy Wayne Prestley, M.D.

According to 2025 Medicare claims, Timothy Prestley, M.D. (NPI: 1548421803) practices neurology in the Tuscaloosa, AL market, with the plurality of this provider's patient population coming from Tuscaloosa, AL. This provider's primary affiliated billing organization is ALPHA NEURON, LLC (NPI: 1477162576; TIN: 85-1925206) and primary practice location at 35401-1090. Prestley is affiliated with the Physician Partners ACO 2, LLC/Select Physicians Associates ACO (ACO ID: A5308), participating under the MSSP model.

Prestley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 462 traditional Medicare patients, billed 54,619 HCPCS/CPT codes, and received $346,969 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 2,057 prescription claims across 403 beneficiaries totaling $3,285,552 in drug costs, led by Vyvgart (Efgartigimod Alfa-Fcab). Open Payments data shows 342 records totaling $80,631. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $288,802 and ending at $346,969. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $5,324 to $3,285,552. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,078	4,053	$288,802
2016	1,070	3,550	$258,495
2017	906	2,982	$229,719
2018	740	20,449	$353,137
2019	883	38,945	$485,720
2020	481	30,627	$316,769
2021	396	39,461	$451,395
2022	395	46,673	$466,011
2023	361	50,635	$336,658
2024	462	54,619	$346,969

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	13	39	$5,324
2016	15	43	$11,696
2017	53	113	$9,064
2018	294	1,379	$209,164
2019	391	1,941	$1,112,491
2020	347	1,794	$1,144,400
2021	347	1,811	$1,643,443
2022	346	1,701	$2,072,647
2023	342	1,769	$2,740,435
2024	403	2,057	$3,285,552

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	104	106	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	89	93	$76
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	124	291	$56
J0588	Injection, incobotulinumtoxin a, 1 unit	63	49,135	$4
96127	Assessment of emotional or behavioral problems	66	70	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vyvgart	Efgartigimod Alfa-Fcab	13	523	$909,196
Soliris	Eculizumab	24	336	$655,442
Gammaplex	Immun Glob G(Igg)/Gly/Iga 0-50	13	322	$349,974
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	22	616	$141,838
Botox	Onabotulinumtoxina	86	6,702	$130,141

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	341	$34,051	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$46,580	Brainsway USA INC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Timothy Wayne Prestley, M.D.?

Tedicare shows public-source Medicare data for Timothy Wayne Prestley, M.D. (NPI 1548421803), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Timothy Wayne Prestley, M.D. have ACO affiliation data?

Timothy Wayne Prestley, M.D. is shown with ACO affiliation data for Physician Partners ACO 2, LLC/Select Physicians Associates ACO (MSSP, ACO ID A5308).

What billing organization is linked to Timothy Wayne Prestley, M.D.?

Timothy Wayne Prestley, M.D. is linked to ALPHA NEURON, LLC (billing NPI 1477162576) in the available physician profile data.

Does Timothy Wayne Prestley, M.D. have Open Payments data?

Timothy Wayne Prestley, M.D. has 342 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.